Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed

Radiotherapy and Oncology

Volumn 92, Issue 3, 2009, Pages 383-387

  Riesterer, Oliver ^a,b   Mason, Kathryn A ^a   Raju, Uma ^a   Yang, Qiuan ^a,c   Wang, Li ^a   Hittelman, Walter N ^a   Ang, K Kian ^a   Milas, Luka ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c SHANDONG UNIVERSITY   (China)

Author keywords

A431; C225; EGFR; Radiation; Tumor bed effect

Indexed keywords

CARBONATE DEHYDRATASE IX; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IRRADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROBABILITY; RADIATION TOLERANCE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 69949173973     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.07.009     Document Type: Article

References (27)

1. Bussink J., Kaanders J.H., and Van der Kogel A.J. Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy. Radiother Oncol 82 (2007) 10-17
2. Baumann M., Krause M., Dikomey E., et al. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms. Radiother Oncol 83 (2007) 238-248
3. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
4. Milas L., Fang F.M., Mason K.A., et al. Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation. Int J Radiat Oncol Biol Phys 67 (2007) 568-572
5. Urano M., and Suit H.D. Experimental evaluation of tumor bed effect for C3H mouse mammary carcinoma and for C3H mouse fibrosarcoma. Radiat Res 45 (1971) 41-49
6. Summers W.C., Clifton K.H., and Vermund H. X-irradiation of the tumor bed. I. A study of the indirect actions of radiation on transplantable tumors. Radiology 82 (1964) 691-703
7. Milas L., Hunter N., and Peters L.J. The tumor bed effect: dependence of tumor take, growth rate, and metastasis on the time interval between irradiation and tumor cell transplantation. Int J Radiat Oncol Biol Phys 13 (1987) 379-383
8. Milas L., Hirata H., Hunter N., and Peters L.J. Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas. Cancer Res 48 (1988) 2116-2120
9. Milas L., Hunter N., and Peters L.J. Tumor bed effect-induced reduction of tumor radiocurability through the increase in hypoxic cell fraction. Int J Radiat Oncol Biol Phys 16 (1989) 139-142
10. Ito H., Barkley Jr. T., Peters L.J., and Milas L. Modification of tumor response to cyclophosphamide and irradiation by preirradiation of the tumor bed: prolonged growth delay but reduced curability. Int J Radiat Oncol Biol Phys 11 (1985) 547-553
11. Milas L., Ito H., Hunter N., Jones S., and Peters L.J. Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type. Cancer Res 46 (1986) 723-727
12. Frankl O., and Kimball C.P. Ueber die Beeinflussung von Mäusetumoren durch Röntgenstrahlen. Wien Klin Wochenschr 27 (1914) 1448-1450
13. Runkel S., Hunter N., and Milas L. An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice. Radiat Res 126 (1991) 237-243
14. Okunieff P., Dols S., Lee J., et al. Angiogenesis determines blood flow, metabolism, growth rate, and ATPase kinetics of tumors growing in an irradiated bed: 31P and 2H nuclear magnetic resonance studies. Cancer Res 51 (1991) 3289-3295
15. Jirtle R., Rankin J.H., and Clifton K.H. Effect of x-irradiation of tumour bed on tumour blood flow and vascular response to drugs. Br J Cancer 37 (1978) 1033-1038
16. Milas L., Mason K., Hunter N., et al. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res 6 (2000) 701-708
17. Bos R., van*Diest P.J., de Jong J.S., van der Groep P., van der Valk P., and van der Wall E. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46 (2005) 31-36
18. Franovic A., Gunaratnam L., Smith K., Robert I., Patten D., and Lee S. Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc Natl Acad Sci USA 104 (2007) 13092-13097
19. Lu Y., Liang K., Li X., and Fan Z. Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1alpha. Mol Cancer 6 (2007) 63
20. Prewett M., Rockwell P., Rockwell R.F., et al. The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma. J Immunother Emphasis Tumor Immunol 19 (1996) 419-427
21. Perrotte P., Matsumoto T., Inoue K., et al. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 5 (1999) 257-265
22. Viloria-Petit A., Crombet T., Jothy S., et al. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis. Cancer Res 61 (2001) 5090-5101
23. Zips D., Eicheler W., Geyer P., et al. Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition. Cancer Res 65 (2005) 5374-5379
24. Kozin S.V., Winkler F., Garkavtsev I., Hicklin D.J., Jain R.K., and Boucher Y. Human tumor xenografts recurring after radiotherapy are more sensitive to anti-vascular endothelial growth factor receptor-2 treatment than treatment-naive tumors. Cancer Res 67 (2007) 5076-5082
25. Krause M., Hessel F., Zips D., Hilberg F., and Baumann M. Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma. Radiother Oncol 72 (2004) 95-101
26. Zips D., Hessel F., Krause M., et al. Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice. Int J Radiat Oncol Biol Phys 61 (2005) 908-914
27. Roda J.M., Joshi T., Butchar J.P., et al. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines. Clin Cancer Res 13 (2007) 6419-6428